5.19
Finanzdaten der Aethlon Medical Inc-Aktie (AEMD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
18.15%
1.5792
|
1.9293 | 2.0621 | 1.5098 | 1.7924 |
| Operating Income/Loss |
18.15%
-1.5792
|
-1.9293 | -2.0621 | -1.5098 | -1.7924 |
| Net Interest Income/Expense |
0.0313
|
- | 0.0439 | 0.0227 | 0.0305 |
| Net Income/Loss |
17.85%
-1.5479
|
-1.8843 | -2.0182 | -1.4871 | -1.7619 |
| Basic Average Shares |
0.3847
|
- | 0.8231 | 0.3975 | -0.0926 |
| Diluted Average Shares |
0.3847
|
- | 0.8231 | 0.3975 | -0.0926 |
| Basic Earnings Per Share |
-4.02
|
- | -2.45 | -3.74 | -0.85 |
| Diluted Earnings Per Share |
-4.02
|
- | -2.45 | -3.74 | -0.85 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):